![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of NS3 Amino Acid Variants in a Phase 1b Study of GT 1 Infection with the HCV Protease Inhibitor, MK-5172
|
|
|
Reported by Jules Levin
19th CROI, Seattle, WA, March 5-8, 2012
Richard Barnard, Julie Strizki, Carolyn McHale, William Newhard,
Carol Cheney, Donald Graham, Amelia Petry, Robert Nachbar, Iain
Fraser, Daria Hazuda
![CROI1.gif](../images/030712/030712-4/CROI1.gif)
![CROI2.gif](../images/030712/030712-4/CROI2.gif)
![CROI3.gif](../images/030712/030712-4/CROI3.gif)
![CROI4.gif](../images/030712/030712-4/CROI4.gif)
![CROI5.gif](../images/030712/030712-4/CROI5.gif)
![CROI6.gif](../images/030712/030712-4/CROI6.gif)
![CROI7.gif](../images/030712/030712-4/CROI7.gif)
![CROI8.gif](../images/030712/030712-4/CROI8.gif)
![CROI9.gif](../images/030712/030712-4/CROI9.gif)
![CROI10.gif](../images/030712/030712-4/CROI10.gif)
![CROI11.gif](../images/030712/030712-4/CROI11.gif)
![CROI12.gif](../images/030712/030712-4/CROI12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|